Scientific Name | Pharmaceutical form | Strength Value |
---|---|---|
Avian Encephalomyelitis Tissue Fluids/Fowl Pox Tissue Fluids |
Lyophilisate for solution for injection |
103- , 102.6- |
Tenosynovitis bulk virus strain 1133 |
Lyophilisate for solution for injection |
103.9- |
Rabies Virus Strain PV-Paris BHK purify Pass 3 SVR-289 |
Solution for injection |
10 7.35- |
Newcastle Disease Virus B 1 Type LaSota Strain/Bronchitis Virus Mass Serotype Strain 1263 |
Lyophilisate for solution for injection |
10^6- , 10^3.8- |
Newcastle Disease Virus- VG GA Avinew strain |
Lyophilisate for suspension |
5.5 - 7.0- |
Inactivated variant coronavirus- PL84084 strain/ Inactivated variant coronavirus- CR88121 strain |
Emulsion for injection |
NLT 2.3- , NLT 2.3- |
Live attenuated Infectious Bronchitis Coronavirus- strain CR88121 |
Lyophilisate for suspension |
4.0 - 5.3- |
Inactivated Avian Reovirus - 1133 Strain/Inactivated Avian Reovirus - 2408 Strain/ Inactivated Avian Reovirus - MSB Strain/ Inactivated Bursal Disease Virus - Variant E Strain/Inactivated Bursal Disease Virus - Standard Strain |
Emulsion for injection |
NLT10ˆ6.97- , NLT10ˆ7.21- , NLT10ˆ7.39- , NLT 10ˆ4.5- , NLT 10ˆ4.7- |
Inactivated Foot and Mouth Disease (FMD)- Serotype A/ Inactivated Foot and Mouth Disease (FMD)- Serotype O/ Inactivated Foot and Mouth Disease (FMD)- Serotype Asia1/Inactivated Foot and Mouth Disease (FMD)- Serotype Sat2 |
Suspension for injection |
NLT 6.0- , NLT 6.0- , NLT 6.0- , NLT 6.0- |
Avian infectious bronchitis virus Massachusetts type strain H120 |
Lyophilisate for suspension |
3.3 log 10log10 EID50/dose |